In the 1970s and ’80s, most lab-based tests were “lower risk, small volume” products used mostly for local patients, according to the FDA. Over time, the tests have grown into a nationwide ...
People want more seafood than the oceans can sustainably supply, so a German firm aims to plug that gap with cultivated fish – but are consumers ready to buy it? The redbrick offices, just north ...
Diamonds are a girl’s best friend, but recently, lab-grown diamonds have been a topic of both intrigue and controversy. This innovative and viable alternative to naturally mined diamonds ...
Patients with moderate to severe hemophilia B can now take Pfizer’s BEQVEZ (fidanacogene elaparvovec-dzkt) with the approval of the FDA. Hemophilia B is an inherited bleeding disorder that ...
In the realm of fine jewelry, lab-grown diamonds have emerged as a revolutionary choice, offering ethical sourcing, environmental sustainability, and exceptional beauty. Among the plethora of options ...
THE US Food and Drug Administration approved Pfizer’s gene therapy for hemophilia B on Friday (Apr 26), the second such therapy for the rare bleeding disorder that typically requires regular infusions ...
Regular lab-grown diamonds, which have been on the market since the 1980s and have exploded in popularity in recent years, take up to 10 weeks to create. But materials scientist Rodney Ruoff and ...
While earlier versions of the device provided a constant level of stimulation, Medtronic’s new product can read signals from nerve fibers and automatically adjust the intensity — a feature ...
The Virginia Board of Education approved $25.4 million for six new lab schools Thursday as state officials find ways to accelerate the approval process to use the existing lab school funding ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ... for BEQVEZ or any other product candidates; whether and when ...
The US Food and Drug Administration (FDA) has approved the gene therapy fidanacogene elaparvovec (Beqvez) for adults with hemophilia B, a rare bleeding disorder that affects almost 4 in 100,000 US ...
The Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S. The ...